India to Mali Pharmaceutical Export (2026) — $71.6M, 156 Suppliers | TransData Nexus

India to Mali Pharmaceutical Export (2026) — $71.6M, 156 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Mali

#	Formulation	Value	Share
1	Sudrek Tablets( Paracetamol BP 325mg + C	$11.9M	16.6%
2	S359348 Mr Vaccine Measles and Rubella	$6.1M	8.5%
3	Atorcap	$4.8M	6.7%
4	Caplin - Metrowin 500 Ovule (metronidazo	$4.4M	6.1%
5	Ladymax Tablets( Paracetamol BP 325mg +	$4.3M	6.0%
6	Flucap	$3.4M	4.7%
7	Arcet Suspension (paracetamol Oral Suspe	$3.1M	4.3%
8	Gastromag Suspension 200ml	$2.8M	3.9%
9	Ibuprofen Tablets BP 800mg Tilol - 800	$2.4M	3.3%
10	Mikagripe Tablets(paracetamol BP 325 MG	$2.3M	3.2%
11	Calben ( Albendazole Chewable Tablets 40	$2.0M	2.8%
12	Prematin Tablets (cyproheptadine Hydroch	$2.0M	2.8%
13	Caplin-cary -250 (erythromycin for Oral	$778.2K	1.1%
14	Dtp-hepb-hib (pentavalent Vaccine) Fullyliquid Combination Vaccine 10 Dose Vial…	$667.2K	0.9%
15	Aurovisc[hydroxypropyl Methylcellulose O	$431.2K	0.6%

India exports 20+ pharmaceutical formulations to Mali with a combined trade value of $71.6M. Key products include Paracetamol ($11.9M), Vaccine ($6.1M), Atorvastatin ($4.8M), Fluconazole ($3.4M), Ibuprofen ($2.4M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 3,324 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Mali Trade Routes

1Paracetamol$11.9M

2Vaccine$6.1M

3Atorvastatin$4.8M

4Fluconazole$3.4M

5Ibuprofen$2.4M

Top Indian Exporters to Mali

1Caplin Point Laboratories Limited

$26.6M

2Unilink Pharma Private Limited

$21.8M

3Biological E Limited

$6.9M

4Kgn Pharmaceuticals Private Limited

$1.5M

5Banson Pharmaceuticals Private Limited

Port Analysis — India to Mali Pharmaceutical Shipments

Indian Export Ports

KAMARAJAR PORT1.9%

VAXENIC INDIA PRIVATE LIMITED (VIPL)-KOLTHUR SEZ0.1%

NHAVA SHEVA SEA (INNSA1)13.3%

KAMARAJAR PORT (INENR1)2.3%

CHENNAI SEA (INMAA1)2.2%

Mali Import Ports

Conakry4.9%

Dakar8.8%

BAMAKO61.0%

Bamako14.1%

DAKAR5.2%

Trade Statistics

Total Value$71.6M

Shipments3,324

Indian Exporters156

Mali Buyers186

Avg Shipment$22K

Products2,498

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Mali Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The India-Mali pharmaceutical trade corridor has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to Mali reached $26.2 million, marking a substantial increase from previous years. This upward trajectory reflects the strengthening of bilateral trade relations and India's expanding presence in the African pharmaceutical market.

Key milestones include the establishment of direct shipping routes and the participation of Indian pharmaceutical companies in Malian trade fairs, enhancing visibility and fostering partnerships. The growth is also attributed to India's competitive pricing, adherence to international quality standards, and the increasing demand for affordable medicines in Mali.

2India's Market Position

India holds a dominant position in Mali's pharmaceutical import market, supplying a significant portion of the country's medicinal needs. In 2023, Mali's total pharmaceutical imports were valued at $238.31 million, with India accounting for approximately $73.03 million, representing a substantial share of the market.

This dominance underscores India's strategic importance as a supplier of essential medicines to Mali, driven by its robust manufacturing capabilities and the ability to meet the diverse healthcare requirements of the Malian population.

Recent Developments

Mali Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export to Mali must navigate a structured registration process overseen by Mali's Directorate of Pharmacy and Medicine (DPM). This process involves submitting a comprehensive product dossier that includes safety and efficacy data, labeling in French, and proof of Good Manufacturing Practice (GMP) or equivalent certification.

The DPM evaluates these submissions to ensure that imported medicines meet the necessary health and safety standards. The timeline for registration can vary, but companies are advised to initiate the process well in advance to accommodate any regulatory reviews or additional requirements.

2GMP & Facility Requirements

Mali requires that pharmaceutical products imported into the country be manufactured in facilities adhering to GMP standards. Indian manufacturers must provide evidence of compliance with these standards, which may include certifications from recognized authorities such as the World Health Organization (WHO).

The DPM conducts inspections to verify compliance, and mutual recognition agreements may facilitate the acceptance of certifications from certain countries. However, Indian exporters should be prepared for potential inspections and ensure that their facilities meet all stipulated requirements.

3Import Documentation

To import pharmaceutical products into Mali, Indian exporters must provide several key documents:

Import Permit: Issued by Mali's Ministry of Health, authorizing the importation of specific pharmaceutical products.

Certificate of Analysis (CoA): Demonstrates that the products meet quality standards.

Commercial Invoice and Packing List: Detailing the shipment contents and value.

Bill of Lading: Proof of shipment.

These documents are submitted to Mali's Customs Authority upon arrival of the goods. Failure to provide the necessary paperwork can result in delays or seizures.

TransData Nexus Research · Mali regulatory databasesMar 2026

FAQ — India to Mali Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Mali?

India exported pharmaceuticals worth $71.6M to Mali across 3,324 verified shipments.

Who are the top Indian pharmaceutical exporters to Mali?

1. CAPLIN POINT LABORATORIES LIMITED — $26.6M. 2. UNILINK PHARMA PRIVATE LIMITED — $21.8M. 3. BIOLOGICAL E LIMITED — $6.9M. Total: 156 suppliers.

Which companies in Mali import pharmaceuticals from India?

1. PHARMA PLUS MALI, S.A. — $25.0M. 2. CICI SARL — $21.7M. 3. XX VAXXINEXXPTEXXIMIXXD — $3.0M. 186 buyers total.

What pharmaceutical products does India export most to Mali?

1. Sudrek Tablets( Paracetamol BP 325mg + C ($11.9M, 16.6%); 2. S359348 Mr Vaccine Measles and Rubella ($6.1M, 8.5%); 3. Atorcap ($4.8M, 6.7%); 4. Caplin - Metrowin 500 Ovule (metronidazo ($4.4M, 6.1%); 5. Ladymax Tablets( Paracetamol BP 325mg + ($4.3M, 6.0%)

Which ports handle pharmaceutical shipments from India to Mali?

Export: KAMARAJAR PORT, VAXENIC INDIA PRIVATE LIMITED (VIPL)-KOLTHUR SEZ, NHAVA SHEVA SEA (INNSA1), KAMARAJAR PORT (INENR1), CHENNAI SEA (INMAA1). Import: Conakry, Dakar, BAMAKO, Bamako, DAKAR.

Why does Mali import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $71.6M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Mali?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Mali pharmaceutical trade?

$21.5K per consignment across 3,324 shipments.

How many Indian pharmaceutical companies export to Mali?

156 Indian companies. Largest: CAPLIN POINT LABORATORIES LIMITED with $26.6M.

How can I find verified Indian pharmaceutical suppliers for Mali?

TransData Nexus covers 156 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Mali identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 3,324 verified shipments from 156 Indian exporters to 186 Mali buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

156 Exporters

186 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Mali Pharmaceutical Export

Top Pharmaceutical Formulations — India to Mali

Top Pharmaceutical Products — India to Mali Trade Routes

Top Indian Exporters to Mali

Port Analysis — India to Mali Pharmaceutical Shipments

Indian Export Ports

Mali Import Ports

Trade Statistics

Other Destinations

India–Mali Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Recent Developments

Top Mali Buyers from India

Product Routes

Full Dataset Access

Mali Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Mali

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Mali

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Mali Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Mali for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Mali

1Competing Origins

2India's Competitive Edge

3Challenges & Threats